As rare disease trials face persistent feasibility challenges, Bayesian designs are gaining momentum by enabling more ...
Despite a trend toward more patient-centered research, quality-of-life end points remain substantially underreported in phase ...
An international, randomized, double-blind, placebo-controlled Phase III study—the largest of its kind for mpox—found that tecovirimat did not improve clinical outcomes for adults with clade II mpox ...
When Elise Felicione tried to design a clinical trial for a supplement, 5 things got in the way. It’s a lesson for the ...
Remote clinical pharmacist impact on reducing total cost of care in Enhancing Oncology Model–enrolled oncology practices. Electronic patient-reported outcome-based weight management versus usual care ...
Systematic review shows GLP 1 receptor agonists trials rarely assess dietary intake, highlighting a major evidence gap in nutrition outcomes.
Clinical trials can vary in length depending on several factors. Here's what you need to know about how long clinical trials last.
Some MS diets may help lower inflammation marker levels, but evidence from clinical trials remains limited, according to a new review paper.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results